Showing 241 - 260 results of 229,277 for search '(( 5 ((ng decrease) OR (mean decrease)) ) OR ( 10 ((we decrease) OR (a decrease)) ))', query time: 1.56s Refine Results
  1. 241

    Pretreatment with terazosin (0.5, 1 mg/kg) reversed the decrease in EEG amplitude produced by modafinil (90 mg/kg, i.p.). by Chang-Rui Chen (467755)

    Published 2013
    “…The arrows indicate the times of the drug injection. Values are means±SEM (n = 5–9). **P<0.01, compared with vehicle control as assessed by one-way repeated ANOVA, followed by PLSD testing.…”
  2. 242
  3. 243

    <i>Ext1</i> mutant lungs exhibit a decrease in SHH-FGF10 signaling. by Hua He (120374)

    Published 2017
    “…Data were presented as mean ± SEM. *<i>p</i><0.05, n≥3. (B-E) Wholemount and section RNA ISH of <i>Fgf10</i> in E12.5 lungs. …”
  4. 244
  5. 245
  6. 246
  7. 247
  8. 248

    Knockdown of AR expression decreases the efficiency of KSHV infection in endothelial cells. by Xing Wang (154377)

    Published 2017
    “…The above cells were infected with KSHV for 2 h at 37°C, washed, and cultured for another 22 h, and the MOIs were 10 and 5 for HUVECs and SLK cells, respectively. …”
  9. 249
  10. 250

    Regulatory B10 cells are augmented and the level of IL-10 expression is decreased in the spleen of AD mice. by Jieqiong Li (327149)

    Published 2015
    “…<p>(A) Representative dot-plots showing the percentage of CD5<sup>+</sup>CD19<sup>+</sup>CD1d<sup>hi</sup> B10 cells in control (n = 10) and AD mice (n = 10); (B) Bar graph depicting the percentage of CD5<sup>+</sup>CD19<sup>+</sup>CD1d<sup>hi</sup>B10 cells in control and AD mice as analyzed by flow cytometry. …”
  11. 251
  12. 252
  13. 253
  14. 254
  15. 255
  16. 256

    Table_1_A phased intervention bundle to decrease the mortality of patients with extracorporeal membrane oxygenation in intensive care unit.pdf by Yajun Jing (11711139)

    Published 2022
    “…</p>Results<p>The cohort included 297 patients in 6 ICUs, mostly VA ECMO (68.7%) with a median (25th–75th percentile) duration in ECMO of 9.0 (4.0–15.0) days. The mean (SD) APECHII score was 24.1 (7.5). Overall, the mortality of ECMO decreased from 57.1% at baseline to 21.8% at 13–18 months after implementation of the study intervention (P < 0.001). …”
  17. 257
  18. 258
  19. 259

    Overexpression of human PGRN mRNA prevents the decrease in axon outgrowth produced by knockdown of zebrafish PGRN. by Angela S. Laird (360986)

    Published 2013
    “…<p>A) The decreased axonal length produced by knockdown of <i>grna</i> with a 5′UTR MO was rescued by co-expression of PGRN mRNA. * significantly different from grna CO MO, p<0.02; ̂ significantly different from <i>grna</i> MO + GFP, p<0.0001. …”
  20. 260